SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001133416-24-000050
Filing Date
2024-08-05
Accepted
2024-08-05 08:38:45
Documents
2
Period of Report
2024-08-02

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 4430
2 poa_jamil.htm EX-24.1 8967
  Complete submission text file 0001133416-24-000050.txt   14922
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 31 DAVID DRIVE NEWTOWN PA 18940
Business Address
Jamil Khurram (Reporting) CIK: 0002032345 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31791 | Film No.: 241173222